MTORC1/2 and HDAC1/2 inhibition promote tumor response through inhibition of MYC

被引：0

作者：

DeStefanis, Rebecca A. ^{[1
]}

Olson, Autumn M. ^{[1
]}

DeZeeuw, Alyssa K. ^{[1
]}

Payne, Susan N. ^{[1
]}

Pasch, Cheri A. ^{[1
]}

Clipson, Linda ^{[1
]}

Deming, Dustin A. ^{[1
]}

机构：

[1] Univ Wisconsin Madison, Madison, WI USA

来源：

CANCER RESEARCH | 2022年 / 82卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1128

引用

页数：2

共 50 条

[31] Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma
Nguyen, Trang T. T.
Shang, Enyuan
Schiffgens, Salveena
Torrini, Consuelo
Shu, Chang
Akman, Hasan Orhan
Prabhu, Varun V.
Allen, Joshua E.
Westhoff, Mike-Andrew
Karpel-Massler, Georg
Siegelin, Markus D.
CLINICAL CANCER RESEARCH, 2022, 28 (09) : 1881 - 1895
[32] INDUCTION OF SYNTHETIC LETHALITY BY ACTIVATION OF MITOCHONDRIAL CLPP AND INHIBITION OF HDAC1/2 IN GLIOBLASTOMA
Nguyen, Trang
Shang, Enyuan
Schiffgens, Salveena
Torrini, Consuelo
Bianchetti, Elena
Shu, Chang
Akman, Hasan Orhan
Prabhu, Varun
Allen, Joshua
Westhoff, Mike-Andrew
Karpel-Massler, Georg
Siegelin, Markus D.
NEURO-ONCOLOGY, 2021, 23 : 201 - 201
[33] AMPK Positively Regulates Neurotensin Secretion Through Inhibition of mTORC1 Signaling
Song, Jun
Li, Jing
Weiss, Heidi L.
Gao, Tianyan
Townsend, Courtney M.
Evers, B. Mark
GASTROENTEROLOGY, 2014, 146 (05) : S87 - S87
[34] The Selective mTORC1, Rather Than Dual mTORC1/2, Inhibition Confers Liver Protection From Ischemia and Reperfusion Injury.
Zhu, J.
Lu, T.
Yue, S.
Shen, X.
Gao, F.
Zhang, M.
Busuttil, R.
Xia, Q.
Kupiec-Weglinski, J.
Zhai, Y.
TRANSPLANTATION, 2014, 98 : 281 - 281
[35] Dual Inhibition of mTORC1/2 Reduces Migration of Cholangiocarcinoma Cells by Regulation of Matrixmetalloproteinases
Joechle, Katharina
Jumaa, Huda
Thriene, Kerstin
Hellerbrand, Claus
Kulemann, Birte
Fichtner-Feigl, Stefan
Lang, Sven A.
Guenzle, Jessica
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
[36] Neuroprotection of resveratrol against cadmium-poisoning acts through dual inhibition of mTORC1/2 signaling
Liu, Chunxiao
Zhang, Ruijie
Yang, Liu
Ji, Tong
Zhu, Cuilan
Liu, Beibei
Zhang, Hai
Xu, Chong
Zhang, Nana
Huang, Shile
Chen, Long
NEUROPHARMACOLOGY, 2022, 219
[37] Copper deprivation enhances the chemosensitivity of pancreatic cancer to rapamycin by mTORC1/2 inhibition
Geng, Ruiman
Ke, Nengwen
Wang, Ziyao
Mou, Yu
Xiang, Bin
Zhang, Zhengkun
Ji, Xuxu
Zou, Jiaqiong
Wang, Dingxue
Yin, Zhaoru
Liu, Xubao
Xie, Fang
Zhao, Yanan
Chen, Dan
Dong, Jingying
Wu, Wenbing
Chen, Lihong
Cai, Huawei
Liu, Ji
CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 382
[38] mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy
Goldman, Kara N.
Chenette, Devon
Arju, Rezina
Duncan, Francesca E.
Keefe, David L.
Grifo, Jamie A.
Schneider, Robert J.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (12) : 3186 - 3191
[39] Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma
Oricchio, Elisa
Katanayeva, Natalya
Donaldson, Maria Christine
Sungalee, Stephanie
Joyce, Pasion P.
Beguelin, Wendy
Battistello, Elena
Sanghvi, Viraj R.
Jiang, Man
Jiang, Yanwen
Teater, Matt
Parmigiani, Anita
Budanov, Andrei V.
Chan, Fong Chun
Shah, Sohrab P.
Kridel, Robert
Melnick, Ari M.
Ciriello, Giovanni
Wendel, Hans-Guido
SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (396)
[40] Inhibition of mTORC1 through ATF4-induced REDD1 and Sestrin2 expression by Metformin
Jang, Se-Kyeong
Hong, Sung-Eun
Lee, Da-Hee
Kim, Ji-Young
Kim, Ji Yea
Ye, Sang-Kyu
Hong, Jungil
Park, In-Chul
Jin, Hyeon-Ok
BMC CANCER, 2021, 21 (01)

← 1 2 3 4 5 →